From the Food and Drug Administration. Interferon alfa approved for Kaposi's sarcoma.
Nightingale
S L
SL
Associate Commissioner for Health Affairs.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000293:Adolescent; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
D007370:Interferon Type I